Poehling Capital Management, Inc. Bristol Myers Squibb CO Transaction History

Poehling Capital Management, Inc.

$390 Million
Q3 2024

A detailed history of Poehling Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Poehling Capital Management, Inc. holds 57,138 shares of BMY stock, worth $3.3 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

57,138

Previous 55,680 2.62%

Holding current value

$3.3 Million

Previous $2.31 Million 27.85%

% of portfolio

0.76%

Previous 0.63%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $57,824 - $75,451	1,458 Added 2.62%	57,138 $2.96 Million
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $1.36 Million - $1.8 Million	-33,890 Reduced 37.84%	55,680 $2.31 Million
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $36,368 - $41,235	758 Added 0.85%	89,570 $4.86 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $7,999 - $9,545	-165 Reduced 0.19%	88,812 $4.56 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $1.51 Million - $1.69 Million	26,067 Added 41.44%	88,977 $5.16 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $83,523 - $92,740	1,311 Added 2.13%	62,910 $4.02 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $1.13 Million - $1.28 Million	17,237 Added 38.86%	61,599 $4.27 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $17,120 - $20,272	-250 Reduced 0.56%	44,362 $3.19 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $5,215 - $3.08 Million	40,120 Added 893.14%	44,612 $4.54 Million
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $2.31 Million - $2.54 Million	-31,804 Reduced 87.62%	4,492 $346,000
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $21,456 - $25,728	349 Added 0.97%	36,296 $2.65 Million
Q4 2021 Jan 10, 2022	BUY	$53.63 - $62.52 $358,462 - $417,883	6,684 Added 22.84%	35,947 $2.24 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $46,625 - $54,616	788 Added 2.77%	29,263 $1.73 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $77,697 - $84,612	1,255 Added 4.61%	28,475 $1.9 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $623,722 - $701,504	10,511 Added 62.91%	27,220 $1.72 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $246,492 - $279,320	4,269 Added 34.32%	16,709 $1.04 Million
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $714,429 - $791,681	12,440 New	12,440 $750,000
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $5,519 - $6,225	-100 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $22,233 - $27,711	-440 Reduced 81.48%	100 $6,000
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $5,992 - $6,898	100 Added 22.73%	540 $34,000
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $26,373 - $28,753	440	440 $27,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Poehling Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Poehling Capital Management, Inc. with notifications on news.

Account

Poehling Capital Management, Inc. Bristol Myers Squibb CO Transaction History